HANOVER, N.H. (AP) — A research team at Dartmouth’s Geisel School of Medicine is getting $5.3 million to study medication-assisted treatment for pregnant women with opioid use disorders.
Officials say combining medication with psychosocial services has been shown to significantly reduce poor outcomes for babies born to mothers with opioid use disorders, but it can be difficult for women to find providers. In northern New England, 5 to 8 percent of newborns have mothers with such disorders.
The team will compare whether integrated care models, where women receive both maternity care and addiction treatment in the same practice, are more effective than providing such treatment in different locations.
The five-year award comes from the Patient-Center Outcomes Research Institute.
Most Read Nation & World Stories
- How to find a quality mask (and avoid counterfeits)
- They relied on rapid COVID tests to gather safely; now some wish they hadn't
- New sequence of images shows Tonga volcano's devastation
- Popular TV anchor catches COVID for a second time: 'This virus is scary'
- Tonga volcano's eruption was so forceful, it may have helped clear Seattle's fog